Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01102257

Dry Eye Assessment and Management: Feasibility Study (DREAM)

Clinical Trial of Essential Fatty Acids for Dry Eye Disease: Feasibility Study

Sponsor: Asbell, Penny, M.D.

Conditions Dry Eye Syndromes Keratoconjunctivitis Sicca

Interventions Olive Oil Omega-3 EFA Supplement

Updated 8 times since 2017 Last updated: Jul 20, 2012 Started: Jan 31, 2010 Primary completion: Jul 31, 2010 Completion: Mar 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Dry Eye Syndromes and Keratoconjunctivitis Sicca and is currently completed. Asbell, Penny, M.D. leads this study, which shows 8 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Dec 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jan 2021 — Dec 2021 [monthly]

Completed PHASE2_PHASE3
Sep 2020 — Jan 2021 [monthly]

Completed PHASE2_PHASE3

▶ Show 3 earlier versions

Jun 2018 — Sep 2020 [monthly]

Completed PHASE2_PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Asbell, Penny, M.D.
National Eye Institute (NEI)

Data source: Asbell, Penny, M.D.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States